I Never Smoked but Was Diagnosed with Terminal Lung Cancer at 27. Here's How Doctors Saved My Life (Exclusive)
Dean Comstock was 27 years old when he received the frightening diagnosis of terminal lung cancer
A singer and runner, he had never smoked
Doctors told him he could live up to three years through chemotherapy, but instead, he chose to undergo a rare double lung transplantIn October 2023, Dean Comstock developed a cough that wouldn't go away. Doctors thought it might be pneumonia or acid reflux. But in August 2024, the runner, musician and singer was diagnosed with stage 4 lung cancer. He had never smoked.
At the time, he was 27 and married to his high school sweetheart. They had just bought a house in Syracuse, New York, and were thinking about starting a family.
Comstock was told he might live one to three years, having chemotherapy every three weeks. He asked if a lung transplant was an option, but was told it was too risky. "Unfortunately, the alternative was certain death," Comstock, now 28, recalls.
Lung cancer is one of the leading causes of death in men and women, both smokers and non-smokers, Dr. Ankit Bharat, chief of thoracic surgery and Director of the Northwestern Medicine Canning Thoracic Institute in Chicago, Ill., says. 'People need to know that lung cancer can kill you even if you don't smoke."
Bharat is a pioneer in lung transplants as part of a clinical trial known as DREAM. He performs transplants on patients with terminal lung cancer confined to their lungs. To his knowledge, Northwestern is the only place in the country that does this.
Bharat connected with Comstock and, in May, performed a double lung transplant to remove his cancer.
'It was the only option,' Bharat says. 'Treatment had failed. He had received all sorts of chemo and immunotargeted therapy, and the cancer was rapidly progressing in both his lungs."
Comstack is currently recovering in Chicago. He shares his story with PEOPLE's Wendy Grossman Kantor.
I woke up one day and felt like I had a cold. I noticed a weird, dry cough but brushed it off. After a few days, I went to the doctor, and they thought it might be pneumonia, so they gave me steroids. After a couple weeks, it didn't get any better, so I was referred to a pulmonologist. They also thought it was pneumonia.
I wasn't getting better, and I was slowing down. I had three jobs: I was a full-time production manager for a manufacturing company, a real estate agent, and my wife McKayla and I perform music at weddings and events. We met in high school — she was sitting at a piano and I asked her to play a piece of music I had composed.
In May 2024, I had to quit my production management job because I no longer had the energy. In August, I got a lung biopsy. Six days later, they called me and my family into the oncologist's office and said, "Dean, you have lung cancer."
I never smoked. I have never even held a cigarette or a joint.
I said, "How bad is it?" And they said, "Stage four," and immediately I was like, "Oh my gosh, this is the end of the world for me. This is it." That was devastating.
Honestly, my first thoughts were not really about me dying, but it was more about leaving McKayla behind. I thought, 'Someone has to be there with her, and that's supposed to be me.' I'm like, 'I can't abandon her.'
Knowing my mom had undergone a double lung transplant in January 2021 for pulmonary fibrosis, my parents asked if it was an option.
The doctor said, "That's not really done for cancer patients."
So, I started a treatment plan of chemotherapy near our home in Syracuse, New York. Doctors said I would be doing what they call 'maintenance chemotherapy' for the rest of my life, every three weeks.
I thought, 'This is awful,' but then I thought, 'Okay, if I have to go to an infusion center every few weeks for the rest of my life for a couple of hours, that's not too much of an inconvenience, as long as I get to live a happy life and I can deal with that."
But eventually I realized that 'the rest of my life' really only meant a few years. They said, "Our goal is to keep you feeling healthy for as long as possible." I said, "How long is that?" And they said, "One to three years."
And then I would be dead.
Meanwhile, my parents didn't accept that a lung transplant wasn't an option. They're like, 'There's got to be a way.' My mom called the transplant team where she got her lungs and said, "My son has stage four lung cancer. Can you help him?" They said, "No, but Northwestern Memorial Hospital in Chicago can."
https://people-app.onelink.me/HNIa/kz7l4cuf
In November 2024, I called Northwestern's transplant team myself and left a voicemail. I told them I had stage four lung cancer and I really needed a transplant. They called back immediately. A few days later, the chief of thoracic surgery, Dr. Ankit Bharat, called and listened to my story. He said, 'This is your only option. I want to help you. I think we can.'
I got a PET scan and a brain MRI around Christmastime and sent them in the mail to Northwestern and filled out more paperwork.
I arrived in Chicago on Saturday, March 1. On Monday, I started three weeks of testing to see if I was eligible for transplant.
By the time insurance approved the transplant, I couldn't walk 10 feet without being completely exhausted and out of breath. I needed three liters of oxygen continuously, every day, all day, and all night — just to sit on the couch. On May 8, I woke up and I needed 10 liters. I more than tripled my oxygen requirement, and by then I could no longer bathe or do anything, really. I couldn't even talk.
On May 14, my coordinator at Northwestern told me to come in for a walk test to measure my oxygen saturation levels. I failed it immediately. I was rushed to the ER and admitted to Northwestern Memorial Hospital, and put on high-flow oxygen.
The next day the lung transplant team called and said, 'Dean, we have lungs for you. Your surgery's tomorrow at 7:00. Do you accept?"
I started laughing and I said, "Of course — I will take these lungs."
The next morning, they wheeled me into this insane room; it was huge with all these machines and metallic tools that I assumed they were going to use to cut me up. They said, "Okay, Dean, here we go." I didn't even cry or feel scared. I was just ready for it because I knew it was my best chance to live.
When I woke from the surgery, I wrote, "I love you," to my wife on a piece of a paper towel and drew a little heart.
On May 17, they took out my intubation tube, and I was able to speak for the first time. I said, "Hi, everyone. I'm cancer-free now."
I spent two weeks in the hospital and two weeks in a rehab facility. I was discharged on June 13. My wife and I celebrated our five-year wedding anniversary later that month.
I'm still getting stronger. My legs are a little wobbly, but I average about a mile a day walking. I still have outpatient rehab three times a week, where I get stronger.
These days, I have so much more energy. Before the surgery, I would sleep most of the day. I would wake up at 9 and need to take a nap by 10. I'd go to bed early, too. But now I can have a full day, and I'm starting to resume normal life.
Before I got sick, I was always hustling, saying yes to everything, not really thinking about my own wants and desires. But now I'm going to have fun, because you never know when it's going to be your last day.
I still have to get cancer screening every three months for the next five years. I just had my first one last week, and there's no evidence of anything cancerous in my body. I feel so lucky to be alive.
You know in the Indiana Jones movies where he's in the tunnel and the wall is coming down and he's trying to get through? I just barely got to the exit.
That's how I feel, like I just made it. Hardly anyone does.
My wife and I will go out for a walk, and she will start crying. When I ask her why, she says, "I'm just so happy. I'm just so happy you're here."
A GoFundMe was established to help the couple.
Read the original article on People
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time Business News
18 minutes ago
- Time Business News
Opening a Rehab Facility: Step-by-Step to Success
A thriving rehab facility starts with a mission that defines both purpose and direction. This mission should be more than inspirational words—it must be a practical guide for decision-making and service design. Identify the specific population you intend to serve, whether it's individuals seeking detox, long-term residential care, or outpatient recovery. Align your treatment philosophy with evidence-based methods that meet their needs. A strong, clearly stated mission not only inspires your team but also attracts clients, partners, and funding sources. Starting a rehab facility requires careful planning, dedication, and an understanding of both regulatory and operational demands. Key elements include securing a suitable location, obtaining proper licensing, and hiring qualified staff with experience in behavioral health and addiction treatment. Financial planning is critical to ensure sustainability, including budgeting for equipment, therapy programs, and day-to-day operations. In addition, creating a safe and therapeutic environment that promotes recovery is essential. When considering what do I need to start a rehab facility, one must also focus on developing structured treatment plans, compliance protocols, and community partnerships to support patient outcomes. Before admitting a single client, your facility must meet a range of regulatory standards. State health departments oversee licensing for behavioral health facilities, with requirements covering staffing qualifications, safety protocols, and patient care standards. On the federal level, HIPAA rules protect patient privacy, while DEA registration is required for handling certain medications. Local zoning ordinances can also impact where your facility can operate. Gaining accreditation from organizations like CARF or The Joint Commission builds credibility and supports insurance reimbursement, making it a wise step early in the process. Sustainability is vital in the behavioral health industry. Develop a business model that balances compassionate care with financial stability. Determine your core revenue streams, such as residential treatment, intensive outpatient programs, aftercare support, and telehealth. Factor in all operating expenses—payroll, utilities, insurance, technology, and marketing—into your budget. Because initial client volumes may be unpredictable, secure adequate funding and maintain a contingency reserve. A well-designed business model ensures your rehab facility can maintain consistent, high-quality services. Quality treatment depends on a strong clinical framework and efficient operations. Choose an evidence-based treatment approach—such as cognitive-behavioral therapy, holistic recovery, or dual-diagnosis programs—and recruit a multidisciplinary team to deliver it. This should include therapists, physicians, case managers, and support staff. On the operational side, implement electronic health records, scheduling systems, and compliance monitoring tools. Establish clear protocols for admissions, care planning, medication management, and crisis intervention to ensure consistency and safety across all services. The physical environment plays a vital role in recovery outcomes. Select a property that offers both accessibility and a peaceful setting conducive to healing. Evaluate proximity to hospitals, transportation, and community resources. Renovations should prioritize safety compliance, ADA accessibility, and a therapeutic atmosphere. Natural lighting, comfortable furnishings, and welcoming communal spaces can help create an environment that feels safe and supportive from the moment a client walks in. To fill your programs, you need a strong marketing and referral strategy. Build a brand identity that conveys trust, professionalism, and empathy. A user-friendly website with search engine optimization (SEO) and targeted online advertising can help reach those seeking treatment. Community outreach—such as hosting informational sessions, partnering with healthcare providers, and engaging with advocacy groups—fosters credibility and trust. Establishing a referral network with hospitals, private practices, and legal professionals can generate a steady stream of client leads. Achieving excellence in behavioral health requires more than dedication; it demands adherence to rigorous quality benchmarks. JCAHO Accreditation for behavioral health plays a pivotal role in guiding organizations toward consistent, safe, and effective patient care. This accreditation evaluates clinical processes, safety protocols, and organizational management to ensure services meet nationally recognized standards. Facilities that attain this recognition not only enhance patient trust but also strengthen operational efficiency and staff accountability. By committing to these standards, behavioral health providers can foster a culture of continuous improvement, delivering care that is both ethical and evidence-based while standing out in a competitive healthcare environment. A phased launch strategy can help your facility adjust smoothly to operational demands. Start with core programs and gradually expand services as systems stabilize and demand increases. Regularly evaluate clinical outcomes, client satisfaction, and financial performance to guide improvements. Invest in ongoing staff training and explore innovative treatment approaches to keep your programs relevant. By remaining adaptable and focused on both quality care and operational efficiency, your rehab facility can grow into a respected leader in recovery services. TIME BUSINESS NEWS


Forbes
16 hours ago
- Forbes
The Downside Of Electric Scooters
As I posted in this column previously, I was in a debilitating electric scooter accident back in April – toppling over the handlebars and smacking my head on the ground. Accomplished at riding these vehicles and feeling invincible, I was shocked as anyone at the extent of damage in my right elbow as a result of the fall. Essentially the nerve up and down my arm popped out of its channel. The pain was excruciating, constant and inescapable. But I'm back, baby. After 10 weeks or so of physical therapy sessions and monotonous daily exercises, the nerve finally returned to its proper place. I almost never feel the numbness or pain anymore.I'm back working. I can sit in a car again. I can sleep on my right side. I can use a fork to eat. I can hit a golf ball, play pickleball, and even ride my bike again. What I won't be doing: Going on an electric my experience is not isolated. In a new study, ERideHero sourced electric scooter injury data from the U.S. Consumer Product Safety Commission's NEISS Database, which collects data on consumer product-related injuries from a sample of 100+ American E.R. departments. The database provides weighting scores for each injury entry, which allowed officials to extrapolate estimatesThe result: In 2024, the number of e-scooter injuries rose by 80 percent, from 64,312 to 115,713. In truth, there were probably a lot more if people like me didn't report any to emergency rooms. Scary. And maybe because they ride more than older people – or because they're less versed at it – children are incurring a higher proportion of e-scooter injuries. Kids younger than 15 had more than double the number of accidents in 2024, from the year before. The age group that suffers the most injuries is 15-to-24-year-olds. More than 10,000 injuries involved riders under the influence last year, as well – 68 percent of alcohol-related e-scooter injuries result in head trauma, compared to just 28 percent among non-alcohol-related study also points out that recent research suggests it's not that electric scooters are intrinsically dangerous, but that it's the behavior or riding style of the users that keeps injury levels high among riders and pedestrians alike. If someone isn't looking – while riding or walking – that can be a recipe for disaster. I witnessed one such incident in downtown San Diego in which an elderly person stepped off a curb and never saw a scooter rider who was flying by. Lots of blood, but somehow the pedestrian was able to walk study also revealed that helmets save lives – 18.42 percent (20,960) of all e-scooter injuries in 2024 were head injuries. This doesn't include injuries to the face and sensory organs. In fact, the head and joints of the extremities commonly take the brunt of a fall. In descending order, the head, face, knee, shoulder and wrist were the top five body parts injured. The elbow – as in my case – was for when these accidents tend to happen, it's on the weekends when I'm guessing more people are riding them. Some 16.29 percent of all e-scooter injuries in 2024 occurred on a Saturday, while 15.12 percent occurred on to make of all this: If you're going to ride an electric scooter, be smart and alert. Watch the pathway ahead of you. Don't go too fast. And wear some padding. I'm guessing I've ridden e-scooters nearly 1,000 times over the past seven years. And if I can fall, anyone can.


NBC News
17 hours ago
- NBC News
FDA warns about unapproved thyroid pills — then says it'll 'ensure access' to them
An unusual about-face that played out at the Food and Drug Administration over the last week illustrated the power of the 'Make America Healthy Again' movement, particularly with its focus on 'natural' drugs. Last Thursday, the agency published a statement saying it had concerns about the safety and effectiveness of unapproved thyroid medications made from animal tissue after it received complaints from patients and reports of adverse events. As a result, the FDA said it had notified drugmakers of its 'intent to take action' against the products, but added that it wouldn't do so immediately to give patients time to switch medications. 'The agency urges patients taking these unapproved animal-derived thyroid medications to treat hypothyroidism to talk to their doctor,' it wrote. The statement in and of itself was nothing surprising. Warnings about unapproved drugs are standard fare for the FDA. What followed also wasn't unheard of: social media backlash. But on Wednesday evening, FDA Commissioner Marty Makary seemingly reversed course, writing in a post on X that the FDA was committed to pursuing the first-ever approval of desiccated thyroid extract, pending results of the ongoing clinical trials. 'In the mean time, we will ensure access for all Americans,' he wrote. Five minutes later, Health Secretary Robert F. Kennedy Jr. responded. 'Love your approach of using gold standard science and common sense, @DrMarkaryFDA,' Kennedy wrote. So, what was this all about? Animal-derived thyroid pills The thyroid — a small, butterfly-shaped gland located at the front of the neck — helps regulate how the body uses energy by producing thyroid hormones. When it doesn't produce enough, it can lead to hypothyroidism, which can cause symptoms including unexplained weight gain, tiredness, sensitivity to cold, changes in menstrual cycles and symptoms of depression and anxiety, according to the Mayo Clinic. The condition is more common in women than men. The standard treatment is prescription thyroid hormone replacement therapy — basically, taking pills that contain the needed thyroid hormones. Typically one of two synthetic hormones, levothyroxine or liothyronine, or a combination of both, are prescribed. Some patients, however, turn to animal-derived thyroid pills either because they don't respond well to the synthetic versions or want to take something marketed as natural, said Dr. Michael Weintraub, an endocrinologist at NYU Langone Health in New York City. The pills — which aren't FDA-approved — are made from dried thyroid glands, usually from pigs, and are sold under brand names like Armour Thyroid, NP Thyroid, Nature-Thyroid and Natural Thyroid, according to the agency. About 1.5 million people in the U.S. were prescribed animal-derived thyroid pills in 2024, the FDA said. In the FDA statement warning against the animal-derived drugs, the agency said they may contain impurities that could result in infections and could also contain inconsistent levels of thyroid hormones, another risk for patients. Taking too much can cause unwanted effects, the FDA said, and too little could not be effective. The backlash In the days that followed the FDA's statement, patients and doctors took to social media to voice their opposition. 'BREAKING FDA set to BAN natural desiccated thyroid medications. Millions rely on these for hypothyroidism who don't respond well to synthetic thyroid pharmaceuticals,' read one post from Will Cole, a functional medicine doctor. 'Let your voice be heard. The FDA needs to change course on this one.' Dave Asprey, the founder of Bulletproof Coffee, a coffee and supplement brand, wrote: 'I found out I had very low thyroid levels in my mid-20s, and Hashimoto's. Normal synthetic thyroid drugs did not work. Natural thyroid extract worked very well and I have been taking it for more than 25 years without a problem.' Dr. Robert Malone — an anti-vaccine activist who was recently appointed by Kennedy to a vaccine advisory panel — called the decision 'terrible news — particularly for postmenopausal women.' He called on doctors and patients to contact the FDA in response. Andrew Nixon, a spokesperson for the Department of Health and Human Services, did not respond to a question about whether Makary's post on Wednesday was in response to social media backlash. When asked about whether the FDA would still take action against unapproved thyroid products, Nixon referred NBC News to the agency's statement last week, which said, 'FDA is not taking immediate action against manufacturers who make unapproved animal-derived thyroid medication to give patients time to transition to an FDA-approved medication to treat their hypothyroidism.' Nixon added that the agency 'will share additional information as it becomes available and as clinical trial results are released.' It's unclear which ongoing trials Makary and Nixon were referring to. lists a trial initiated by Walter Reed National Military Medical Center in 2012, but the trial's status is currently marked as 'unknown.' Allergan, the maker of Armour Thyroid, completed a trial in 2021 comparing its product to levothyroxine, a synthetic thyroid hormone. So, are these pills safe? Dr. Pieter Cohen, an associate professor of medicine at Harvard Medical School, said the FDA was correct to issue its initial warning about the thyroid pills, noting that the animal-derived pills aren't regulated by the agency and can pose significant risks. The FDA-approved synthetic versions usually replace one of two thyroid hormones: T4, the main hormone the thyroid produces, or T3, the active form of T4 that helps regulate energy and metabolism. Companies that make FDA-approved drugs must follow certain regulations, including consistent dosing. The animal-derived versions also contain the thyroid hormones, just like prescription medications, Cohen said, but because they're unregulated, the amount they contain can be all over the place. 'Getting too much or too little thyroid hormone has long-term health risks,' he said. 'If you take too much, it can damage your bones, it can damage your heart. If you take too little, if you're not getting enough, a number of problems can occur too, including mood problems, like depression.' Weintraub, of NYU Langone Health, said that tiny changes in thyroid hormone levels can have a big impact, so it's important to get the dosage right. He noted that pigs naturally have much higher levels of T3 than humans. 'It can lead to heart rhythm disturbances, which can be life-threatening. It can lead to bone degradation, which can lead to broken bones,' he said. Weintraub said he's had patients who took animal-derived thyroid pills who've had issues with sleeping, had sensitivity to heat or developed osteoporosis. Dr. Susan Spratt, an endocrinologist and senior medical director for the Population Health Management Office at Duke Health in North Carolina, however, said that it would be unfair for the FDA to 'suddenly yank' the animal-derived versions from the market 'without dedicated reasons that they are harmful.' Spratt said that the animal-derived pills have been around for decades as a prescribable drug. (Weintraub said the animal-derived drugs were 'grandfathered in,' meaning they were already on the market before current FDA standards for safety were put into place.) While Spratt said she prefers to prescribe the FDA-approved synthetic versions, the animal-derived versions offer an option for people who don't respond well to the synthetic ones. 'I would welcome NIH funding on why some patients don't feel as good on T4-only products,' she said. Weintraub said the synthetic versions don't 'necessarily help everyone's symptoms, but there's a more precise and safer way of treating that than resorting to a pig or cow thyroids.' He said patients who don't respond well to T4- or T3-only medications often do better on a combination of the two.